![Frederick Farhad Fahid](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frederick Farhad Fahid
Directeur/Membre du Conseil chez De Novo Pharmaceuticals Ltd.
Postes actifs de Frederick Farhad Fahid
Sociétés | Poste | Début | Fin |
---|---|---|---|
De Novo Pharmaceuticals Ltd.
![]() De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 05/11/2014 | - |
Historique de carrière de Frederick Farhad Fahid
Statistiques
Internationale
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
De Novo Pharmaceuticals Ltd.
![]() De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Frederick Farhad Fahid
- Expérience